Skip to main content

Table 3 Distribution of HR-HPV types according to cervical intraepithelial neoplasia

From: Distribution of human papillomavirus in precancerous and cancerous cervical neoplasia in Tunisian women

  CC CINI CINII/CINIII Total
n (%) n (%) n (%)
HPV16 9 (24.3%) 21 (56.7%) 7 (18.9%) 37
HPV18 8 (53.3%) 2 (13.3%) 5 (33.3%) 15
HPV31 0 (0.0%) 7 (100.0%) 0 (0.0%) 7
HPV33 0 (0.0%) 2 (100.0%) 0 (0.0%) 2
HPV35 2 (25%) 3 (37.5%) 3 (37.5%) 8
HPV39 0 (0.0%) 5 (100.0%) 0 (0.0%) 5
HPV45 4 (57.5%) 1 (14.2%) 2 (28.5%) 7
HPV51 0 (0.0%) 5 (83.3%) 1 (16.6%) 6
HPV52 0 (0.0%) 3 (100.0%) 0 (0.0%) 3
HPV53 3 (37.5%) 5 (62.5%) 0 (0.0%) 8
HPV56 0 (0.0%) 1 (100.0%) 0 (0.0%) 1
HPV58 2 (100.0%) 0 (0.0%) 0 (0.0%) 2
HPV59 3 (100.0%) 0 (0.0%) 0 (0.0%) 3
HPV66 2 (50.0%) 2 (50.0%) 0 (0.0%) 4
HPV68 1 (100.0%) 0 (0.0%) 0 (0.0%) 1
HPV70 0 (0.0%) 3 (100.0%) 0 (0.0%) 3
  1. CINI cervical intraepithelial neoplasia I, CINII cervical intraepithelial neoplasia II, CINIII cervical intraepithelial neoplasia III